Cargando…
A peptide puzzle
Why does cancer develop in situations where the immune system is perfectly capable of eliminating it?
Autores principales: | Guan, Jian, Shastri, Nilabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286122/ https://www.ncbi.nlm.nih.gov/pubmed/30526851 http://dx.doi.org/10.7554/eLife.41524 |
Ejemplares similares
-
Non-conventional sources of peptides presented by MHC class I
por: Starck, Shelley R., et al.
Publicado: (2011) -
Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules
por: Sahara, Hiroeki, et al.
Publicado: (2003) -
Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
por: Mantis, Christine, et al.
Publicado: (2017) -
An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021) -
Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines
por: Schepsky, Alexander, et al.
Publicado: (2020)